Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 337 participants.
Also called NCT01545388
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 337 participants
- Sponsor
- Registry
-
NCT01545388
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01545388. Randomized; double masking; primary purpose treatment. Start 2012-02-23 (actual); primary completion 2013-03-12 (actual). Results posted on 2014-03-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Sitagliptin
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct01545388- Content hash
2c621ff54351e986ae0b3a3bb803c7804385b7b9c5300c69eaeefcec53d92dde